357 related articles for article (PubMed ID: 12968395)
1. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
Guerra F; Daza JC; Almeda E
J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
[TBL] [Abstract][Full Text] [Related]
2. Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae.
Ferrer A; García-Sellés J
J Investig Allergol Clin Immunol; 2003; 13(4):244-51. PubMed ID: 14989113
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life.
Alvarez-Cuesta E; Aragoneses-Gilsanz E; Martín-Garcia C; Berges-Gimeno P; Gonzalez-Mancebo E; Cuesta-Herranz J
Clin Exp Allergy; 2005 May; 35(5):572-8. PubMed ID: 15898977
[TBL] [Abstract][Full Text] [Related]
4. Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of dermatophagoides pteronyssinus.
Ibero M; Castillo MJ
J Investig Allergol Clin Immunol; 2006; 16(3):194-202. PubMed ID: 16784014
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with an extract of Olea europaea quantified in mass units. Evaluation of the safety and efficacy after one year of treatment.
González P; Florido F; Sáenz de San Pedro B; de la Torre F; Rico P; Martín S
J Investig Allergol Clin Immunol; 2002; 12(4):263-71. PubMed ID: 12926186
[TBL] [Abstract][Full Text] [Related]
6. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica.
García-Sellés J; Pascual A; Funes E; Pagán JA; López JD; Negro JM; Hernández J
Allergol Immunopathol (Madr); 2003; 31(2):63-9. PubMed ID: 12646120
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
Colás C; Monzón S; Venturini M; Lezaun A
J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
10. Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts.
Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
Clin Exp Allergy; 2007 Mar; 37(3):434-40. PubMed ID: 17359393
[TBL] [Abstract][Full Text] [Related]
11. Skin tests with native, depigmented and glutaraldehyde polymerized allergen extracts.
Casanovas M; Gómez MJ; Carnés J; Fernández-Caldas E
J Investig Allergol Clin Immunol; 2005; 15(1):30-6. PubMed ID: 15864880
[TBL] [Abstract][Full Text] [Related]
12. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts.
Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
Int Arch Allergy Immunol; 2006; 139(2):153-8. PubMed ID: 16374026
[TBL] [Abstract][Full Text] [Related]
13. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
[TBL] [Abstract][Full Text] [Related]
14. Desensitization effect of preseasonal seven-injection allergoid immunotherapy with olive pollen on basophil activation: the efficacy of olive pollen-specific preseasonal allergoid immunotherapy on basophils.
Gokmen NM; Ersoy R; Gulbahar O; Ardeniz O; Sin A; Unsel M; Kokuludag A
Int Arch Allergy Immunol; 2012; 159(1):75-82. PubMed ID: 22572984
[TBL] [Abstract][Full Text] [Related]
15. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
16. Why are nasal and bronchial symptoms mostly perennial in patients with monosensitization to Olea europaea pollen allergens?
Liccardi G; Kordash TR; Russo M; Noschese P; Califano C; D'Amato M; D'Amato G
J Investig Allergol Clin Immunol; 1996; 6(6):371-7. PubMed ID: 9015781
[TBL] [Abstract][Full Text] [Related]
17. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
[TBL] [Abstract][Full Text] [Related]
18. Double-blind study of tolerability and antibody production of unmodified and chemically modified allergen vaccines of Phleum pratense.
Casanovas M; Sastre J; Fernández-Nieto M; Lluch M; Carnés J; Fernández-Caldas E
Clin Exp Allergy; 2005 Oct; 35(10):1377-83. PubMed ID: 16238799
[TBL] [Abstract][Full Text] [Related]
19. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Phleum pratense depigmented allergoid vaccines: experimental study in rabbits.
Iraola V; Gallego MT; López-Matas MA; Morales M; Bel I; García N; Carnés J
J Investig Allergol Clin Immunol; 2012; 22(1):35-40. PubMed ID: 22448452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
